Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/29/2025

Evaluation and Management of Nipple Discharge

Initial Clinical Assessment

  • The American College of Radiology recommends characterizing nipple discharge as physiologic or pathologic, followed by diagnostic mammography and ultrasound if pathologic features are present, as malignancy risk is 10% in this age group 1, 2
  • Pathologic discharge is defined as unilateral, spontaneous, or serous/bloody, and any single pathologic feature warrants full evaluation 1, 3, 4
  • Physiologic discharge is bilateral, from multiple ducts, white, green, or yellow in color, and only occurs with provocation/manipulation 1, 3, 4
  • If physiologic and screening mammography is current, no radiologic investigation is needed 2, 4

Malignancy Risk Stratification

  • The cancer risk in a 40-year-old patient with pathologic nipple discharge is 10%, increasing to 32% after age 60 1, 3, 4
  • Key risk factors that increase malignancy likelihood include presence of palpable mass, male sex, and age >60 years 1, 3, 4
  • Presence of palpable mass increases risk to 61.5% vs 6.1% without mass 1, 3, 4
  • Male sex has a malignancy rate of 23-57% in men with nipple discharge 1, 3, 4
  • Age >60 years has a malignancy rate of 32% 1, 3, 4

Imaging Algorithm for Pathologic Discharge

  • Diagnostic Mammography or Digital Breast Tomosynthesis (DBT) is the first-line modality for patients ≥40 years, with sensitivity 15-68% and specificity 38-98% for malignancy detection 2, 5
  • Breast Ultrasound is usually complementary to mammography, with sensitivity 63-100% for detecting intraductal lesions, and can be used as initial modality if patient recently had mammogram or is pregnant 2, 5, 7
  • MRI Breast (with and without IV contrast) is reserved for cases where mammography and ultrasound are negative but pathologic discharge persists, with sensitivity 86-100% for detecting causes of pathologic nipple discharge 1, 3, 4, 6

Management Based on Imaging Results

  • If imaging shows suspicious lesion, image-guided core biopsy (preferred over FNA) provides tissue diagnosis for definitive pathologic assessment 2, 5
  • If imaging is negative, consider MRI for persistent pathologic discharge, and surgical duct excision is no longer standard for all cases of pathologic discharge 1, 3, 4

Common Etiologies

  • Most common causes of pathologic discharge include intraductal papilloma (35-48%), duct ectasia (17-36%), and malignancy (5-21% overall, 10% at age 40) 1, 3, 4

REFERENCES

7

Imaging Modalities for Nipple Mass Detection [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025